Tscan Therapeutics (TCRX) traded down -6.4 % during a 24 hours period ending at 06:09 AM Central Europe on Wednesday 28th. One Tscan Therapeutics stock can currently be bought for about USD 0.19 on popular exchanges. Current supply of Tscan Therapeutics stocks is 67.8 mn. Tscan Therapeutics has a current market capitalization of USD 13.6 mn and approximately USD 152.2 k worth of Tscan Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Tscan Therapeutics has traded -44.12 % down. Simple moving average of last 200 days is at USD 0.87. The highest price of past 52 weeks was recorded at USD 2.14 on 10/29/2025. 52 weeks low was at USD 0.18 on 10/26/2026.
Here is how related stocks have performed in the past 24 hours:
Pavmed (PAVM) traded up 4.15 % and now trades at USD 2.14. Current market capitalisation for Pavmed is USD 15.5 mn.
Prostar (MAPPF) traded up 4.55 % and now trades at USD 0.1. Prostar has a market capitalisation of USD 15.7 mn.
T Stamp (IDAI) traded down -12.5 % and now trades at USD 2.4. T Stamp has a market capitalisation of USD 15.3 mn.
Marker Therapeutics (MRKR) traded down -5.21 % and now trades at USD 0.95. Marker Therapeutics has a market capitalisation of USD 15.8 mn.
Accendra Health (ACH) traded down -9.09 % and now trades at USD 0.2. Accendra Health has a market capitalisation of USD 16.2 mn.
About Tscan Therapeutics
TScan Therapeutics, Inc. is a biotech company that specializes in developing T cell therapies for patients to unlock the potential of their human immune systems. The company operates globally, serving customers worldwide. You can find more information about their activities and offerings on their website at www.tscan.com , and they are traded on the Nasdaq stock exchange.